Skip to main content

Table 5 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer per each SD increase in dietary advanced glycation end products (AGEs) based on menopausal status

From: Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults

 

Pre-menopause

Post-menopause

 

OR (95% CI)

P-value

OR (95% CI)

P-value

Z score of dietary AGEs

41,950

3626

Case/Total

62 / 215

72 / 186

Model 1*

0.84 (0.61–1.16)

0.300

1.17 (0.87–1.57)

0.285

Model 2†

0.96 (0.64–1.43)

0.849

1.65 (1.11–2.46)

0.013

Model 3‡

0.94 (0.62–1.44)

0.798

1.62 (1.08–2.43)

0.019

Model 4¶

0.94 (0.61–1.46)

0. 803

1.70 (1.11–2.60)

0.014

  1. *Model 1: Crud model
  2. †Model 2: Adjusted for age, first pregnancy age, and energy intake
  3. ‡ Model3: adjusted for model 2 and family history of cancer, anti-inflammatory drug use, Vitamin D supplementation, physical activity
  4. ¶ Model 4: adjusted for model 3 and BMI, number of childbirths, and history of abortion, breastfeeding, and OCP use